A, S., T, B., F, Z., AL, S., J, H., P, H., . . . A, B. (2026). A systematic review of short-term outcomes in patients with anti-factor H associated atypical HUS managed with plasma exchanges versus eculizumab. Pediatric nephrology (Berlin, Germany), 41(12), 4369. https://doi.org/10.1007/s00467-026-07309-3
Chicago Style (17th ed.) CitationA, Sinha, Bindal T, Zotta F, Sellier-Leclerc AL, Hogan J, Hari P, Vivarelli M, and Bagga A. "A Systematic Review of Short-term Outcomes in Patients with Anti-factor H Associated Atypical HUS Managed with Plasma Exchanges Versus Eculizumab." Pediatric Nephrology (Berlin, Germany) 41, no. 12 (2026): 4369. https://doi.org/10.1007/s00467-026-07309-3.
MLA (9th ed.) CitationA, Sinha, et al. "A Systematic Review of Short-term Outcomes in Patients with Anti-factor H Associated Atypical HUS Managed with Plasma Exchanges Versus Eculizumab." Pediatric Nephrology (Berlin, Germany), vol. 41, no. 12, 2026, p. 4369, https://doi.org/10.1007/s00467-026-07309-3.